Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 1Melanoma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Exanthema 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

benralizumab 1Triamcinolone Acetonide 1Tetracycline 1Sirolimus 1Panitumumab 1Minocycline 1Irinotecan 1IFL protocol 1Hydrocortisone 1Gels 1Fulvestrant 1Erlotinib Hydrochloride 1Dapsone 1Clindamycin 1Anti-Bacterial Agents 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Exanthema × Anti-Bacterial Agents × Clear all
NCT01931150 2017-01-13

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
11 enrolled 7 charts
Gastrointestinal

Exanthema, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡